Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy

Introduction: Proteinuria is a common complication in patients with type 2 diabetic nephropathy (DN). The aim of this study was to evaluate the anti-proteinuria effect of active vitamin D in patients with type 2 DN. Methods: A double-blind randomized clinical trial study was conducted on 42 DN patie...

Full description

Bibliographic Details
Main Authors: Asieh Aref, Mina Khodhal, Homeira Rashidi, Zahra Farhangiyan, Saeid Bitaraf
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=12;spage=7735;epage=7742;aulast=Aref
_version_ 1797904869057626112
author Asieh Aref
Mina Khodhal
Homeira Rashidi
Zahra Farhangiyan
Saeid Bitaraf
author_facet Asieh Aref
Mina Khodhal
Homeira Rashidi
Zahra Farhangiyan
Saeid Bitaraf
author_sort Asieh Aref
collection DOAJ
description Introduction: Proteinuria is a common complication in patients with type 2 diabetic nephropathy (DN). The aim of this study was to evaluate the anti-proteinuria effect of active vitamin D in patients with type 2 DN. Methods: A double-blind randomized clinical trial study was conducted on 42 DN patients selected by convenience sampling method. After selecting patients based on inclusion criteria, they were randomly divided into control and intervention groups. Patients in the intervention group received 0.25 mg of active vitamin D per day for 12 weeks. The variables evaluated in the patients on the first day of the intervention included fasting blood sugar (FBS), calcium, phosphorus, creatinine, glomerular filtration rate (GFR), systolic and diastolic blood pressure, and proteinuria. These variables were also evaluated at the end of the first, second, and third month of intervention. Data were collected and analyzed in Statistical Package for Social Sciences software version 22. Results: Around 52.5% of the patients participating in this study were male and 47.5% were female. The mean age of the patients was 55.52 ± 6.58 years. The results of repeated measures analysis showed that active vitamin D significantly reduced proteinuria (P = 0.000) in patients in the intervention group. The changes in FBS (P = 0.235), calcium (P = 0.393), phosphorus (P = 0.694), creatinine (P = 0.232), GFR (P = 0.347), systolic blood pressure (P = 0.615), and diastolic blood pressure (P = 0.115) were not significant in patients in the intervention group. Conclusion: Prescription of active vitamin D can significantly reduce the incidence of proteinuria in patients with DN.
first_indexed 2024-04-10T09:55:46Z
format Article
id doaj.art-b6f18fe417ff4d09b06c6daeb3c6948d
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-04-10T09:55:46Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-b6f18fe417ff4d09b06c6daeb3c6948d2023-02-16T12:30:40ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-0111127735774210.4103/jfmpc.jfmpc_627_22Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathyAsieh ArefMina KhodhalHomeira RashidiZahra FarhangiyanSaeid BitarafIntroduction: Proteinuria is a common complication in patients with type 2 diabetic nephropathy (DN). The aim of this study was to evaluate the anti-proteinuria effect of active vitamin D in patients with type 2 DN. Methods: A double-blind randomized clinical trial study was conducted on 42 DN patients selected by convenience sampling method. After selecting patients based on inclusion criteria, they were randomly divided into control and intervention groups. Patients in the intervention group received 0.25 mg of active vitamin D per day for 12 weeks. The variables evaluated in the patients on the first day of the intervention included fasting blood sugar (FBS), calcium, phosphorus, creatinine, glomerular filtration rate (GFR), systolic and diastolic blood pressure, and proteinuria. These variables were also evaluated at the end of the first, second, and third month of intervention. Data were collected and analyzed in Statistical Package for Social Sciences software version 22. Results: Around 52.5% of the patients participating in this study were male and 47.5% were female. The mean age of the patients was 55.52 ± 6.58 years. The results of repeated measures analysis showed that active vitamin D significantly reduced proteinuria (P = 0.000) in patients in the intervention group. The changes in FBS (P = 0.235), calcium (P = 0.393), phosphorus (P = 0.694), creatinine (P = 0.232), GFR (P = 0.347), systolic blood pressure (P = 0.615), and diastolic blood pressure (P = 0.115) were not significant in patients in the intervention group. Conclusion: Prescription of active vitamin D can significantly reduce the incidence of proteinuria in patients with DN.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=12;spage=7735;epage=7742;aulast=Arefactive vitamin danti-proteinuriadiabetic nephropathytype 2 diabetes mellitus
spellingShingle Asieh Aref
Mina Khodhal
Homeira Rashidi
Zahra Farhangiyan
Saeid Bitaraf
Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
Journal of Family Medicine and Primary Care
active vitamin d
anti-proteinuria
diabetic nephropathy
type 2 diabetes mellitus
title Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
title_full Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
title_fullStr Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
title_full_unstemmed Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
title_short Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
title_sort anti proteinuria effect of active vitamin d in patients with type 2 diabetic nephropathy
topic active vitamin d
anti-proteinuria
diabetic nephropathy
type 2 diabetes mellitus
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=12;spage=7735;epage=7742;aulast=Aref
work_keys_str_mv AT asieharef antiproteinuriaeffectofactivevitamindinpatientswithtype2diabeticnephropathy
AT minakhodhal antiproteinuriaeffectofactivevitamindinpatientswithtype2diabeticnephropathy
AT homeirarashidi antiproteinuriaeffectofactivevitamindinpatientswithtype2diabeticnephropathy
AT zahrafarhangiyan antiproteinuriaeffectofactivevitamindinpatientswithtype2diabeticnephropathy
AT saeidbitaraf antiproteinuriaeffectofactivevitamindinpatientswithtype2diabeticnephropathy